Report Feature
The future of the global nucleic-acid therapeutic market looks promising with opportunities in hospitals, and academic and research institutes. The global nucleic-acid therapeutic market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are lower rate of cure for genetic diseases with traditional drugs, rising awareness among people related to human genetics, and increasing power of softwares to mimic human molecular entities such as receptors.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global nucleic-acid therapeutics market report, please download the report brochure.
In this market, monogenetic disorders is the largest application of nucleic-acid therapeutic. Growth in various segments of the nucleic-acid therapeutic market are given below:
The study includes trends and forecast for the global nucleic-acid therapeutic market by technology, application, end user, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Anti-Sense And Anti-Gene
- Short Inhibitory Sequences
- Gene Transfer Therapy
- Nucleoside Analogs
- Ribozymes
- Aptamers
- Others
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Monogenetic Disorders
- Multi-Genetic Disorders
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hospitals
- Academic & Research Institutes
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the nucleic-acid therapeutic companies profiled in this report include Wave Life Sciences, Copernicus Therapeutics, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN (Expression Genetics), Benitec Biopharma, and BioMedica (Oxford BioMedica).
Within this market, monogenetic disorders will remain the largest segment by application over the forecast period due to rising awareness of people towards genetic disorders.
North America will remain the largest region over the forecast period due to the presence of excellent reimbursment scenario, strong research base, and the rapid development of new drugs and technology.
|
Features of the Global Nucleic-Acid Therapeutic Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global nucleic-acid therapeutics market by technology (anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, and others), application (monogenetic disorders and multi-genetic disorders), end user (hospitals, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global nucleic-acid therapeutics market? Q.5 What are the business risks and threats to the global nucleic-acid therapeutics market? Q.6 What are the emerging trends in this nucleic-acid therapeutics market and the reasons behind them? Q.7 What are some changing demands of customers in this nucleic-acid therapeutics market? Q.8 What are the new developments in this nucleic-acid therapeutics market? Which companies are leading these developments? Q.9 Who are the major players in this nucleic-acid therapeutics market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this nucleic-acid therapeutics market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global nucleic-acid therapeutics market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Technology (Anti-Sense and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others), Application (Monogenetic Disorders and Multi-Genetic Disorders), and End User (Hospitals, Academic & Research Institutes, and Others) |
|
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Nucleic-Acid Therapeutics Market
4.1 Global Nucleic-Acid Therapeutics Market by Region
4.2.1 Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.2.2 Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.2.3 Market by End User: Hospitals, Academic & Research Institutes, and Others
4.2.4 The United States Nucleic-Acid Therapeutics Market
4.2.5 The Canadian Nucleic-Acid Therapeutics Market
4.2.6 The Mexican Nucleic-Acid Therapeutics Market
4.3.1 Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.3.2 Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.3.3 Market by End User: Hospitals, Academic & Research Institutes, and Others
4.3.4 The Nucleic-Acid Therapeutics Market of United Kingdom
4.3.5 The Spanish Nucleic-Acid Therapeutics Market
4.3.6 The German Nucleic-Acid Therapeutics Market
4.3.7 The French Nucleic-Acid Therapeutics Market
4.4.1 Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.4.2 Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.4.3 Market by End User: Hospitals, Academic & Research Institutes, and Others
4.4.4 The Chinese Nucleic-Acid Therapeutics Market
4.4.5 The Indian Nucleic-Acid Therapeutics Market
4.4.6 The Japanese Nucleic-Acid Therapeutics Market
4.5.1 Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.5.2 Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.5.3 Market by End User: Hospitals, Academic & Research Institutes, and Others
4.5.4 Brazilian Nucleic-Acid Therapeutics Market
7.1.1 Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by Technology
7.1.2 Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by Application
7.1.3 Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by End User
7.1.4 Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
